Literature DB >> 9827787

The value of screening for psychiatric disorders in rheumatology referrals.

P G O'Malley1, J L Jackson, K Kroenke, K Yoon, E Hornstein, G J Dennis.   

Abstract

BACKGROUND: Musculoskeletal complaints are common and often unexplained and often lead to rheumatology referrals. The prevalence of psychiatric disease in patients with musculoskeletal complaints is unknown.
OBJECTIVES: To determine the prevalence of common psychiatric disorders among patients referred to a rheumatology clinic and the likelihood of establishing a rheumatic diagnosis if a psychiatric disorder is present.
DESIGN: Prospective diagnostic survey.
SETTING: Two hospital-based rheumatology clinics and a general medicine clinic. PARTICIPANTS: A consecutive sample of newly referred patients (n = 185) and their rheumatologists (n = 9). INTERVENTION: Before their visit, all patients filled out a self-administered version of PRIME-MD (Primary Care Evaluation of Mental Disorders), a questionnaire that makes Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: Primary Care Version, diagnoses of depressive, anxiety, and somatoform disorders. After the visit, the study rheumatologists, who were unaware of the PRIME-MD results, completed a questionnaire regarding their diagnostic assessment. These patients were compared with 210 patients with musculoskeletal complaints who were cared for in a general medicine clinic. MAIN OUTCOME MEASURES: Psychiatric and rheumatic disorders.
RESULTS: Compared with patients with musculoskeletal complaints in a general medicine clinic, patients referred to a rheumatology clinic had a higher prevalence of psychiatric disease (40% vs 29%; P = .008), had an almost 2-fold higher prevalence of anxiety disorders, and were more likely to have multiple psychiatric disorders (odds ratio = 2.70, 95% confidence interval = 1.50-5.00). The likelihood of a psychiatric disorder differed among patients with connective tissue disease, nonsystemic articular or periarticular disorders, and nonarticular disorders (27%, 38%, 55%, respectively; P = .006). In a best-fitting logistic regression model, psychiatric disorders markedly decreased the likelihood of a connective tissue disease (odds ratio = 0.24, 95% confidence interval = 0.09-0.62).
CONCLUSIONS: Forty percent of patients referred to a rheumatology clinic in this study had a psychiatric disorder, and its presence predicted a lower likelihood of a connective tissue disease. Prospective studies are needed to determine if screening for psychiatric disease before referring patients with unexplained musculoskeletal complaints would reduce costs or improve recognition of potentially treatable psychiatric disorders.

Entities:  

Mesh:

Year:  1998        PMID: 9827787     DOI: 10.1001/archinte.158.21.2357

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  14 in total

1.  Impact of pain severity and location on health-related quality of life.

Authors:  Dennis C Ang; Kurt Kroenke; Colleen A McHorney
Journal:  Rheumatol Int       Date:  2005-08-11       Impact factor: 2.631

2.  Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated.

Authors:  Panagiota Anyfanti; Eleni Gavriilaki; Athina Pyrpasopoulou; George Triantafyllou; Areti Triantafyllou; Sofia Chatzimichailidou; Eugenia Gkaliagkousi; Spyros Aslanidis; Stella Douma
Journal:  Clin Rheumatol       Date:  2014-05-25       Impact factor: 2.980

3.  Serious psychological distress in U.S. adults with arthritis.

Authors:  Margaret Shih; Jennifer M Hootman; Tara W Strine; Daniel P Chapman; Teresa J Brady
Journal:  J Gen Intern Med       Date:  2006-07-19       Impact factor: 5.128

4.  The outcomes among patients presenting in primary care with a physical symptom at 5 years.

Authors:  Jeffrey L Jackson; Mark Passamonti
Journal:  J Gen Intern Med       Date:  2005-11       Impact factor: 5.128

5.  Psychological distress and quality of life are improved in autoimmune patients through Tandem-Psychotherapy, combining individual hypnosis and eye movement desensitization and reprocessing (EMDR) treatment for trauma, followed by supportive-expressive group therapy.

Authors:  Maria Teresa Corsetti; Edoardo Rossi; Sofia Bonvino; Pietro Randazzo
Journal:  Clin Rheumatol       Date:  2019-12-19       Impact factor: 2.980

6.  The long-term costs of traumatic stress: intertwined physical and psychological consequences.

Authors:  Alexander C McFarlane
Journal:  World Psychiatry       Date:  2010-02       Impact factor: 49.548

7.  Mental Health Screening of Older Adults in Primary Care.

Authors:  Mary J Davis; Jennifer Moye; Michele J Karel
Journal:  J Ment Health Aging       Date:  2002

Review 8.  Psychological determinants of fibromyalgia and related syndromes.

Authors:  J B Winfield
Journal:  Curr Rev Pain       Date:  2000

Review 9.  Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management.

Authors:  Kurt Kroenke
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

10.  Depression and its correlation with in patients pain in the rheumatology service of a Mexican teaching hospital.

Authors:  Antonio Kobayashi-Gutiérrez; Gloria Martinez-Bonilla; Ana Guillaisne Bernard-Medina; Rogelio Troyo-Sanroman; Verónica González-Díaz; Esteban Castro-Contreras; Eduardo Vázquez-Valls; Blanca Miriam Torres-Mendoza
Journal:  Rheumatol Int       Date:  2008-12-27       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.